Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 34

Sort by

Sort Order Select

Journal Articles

New HLA-DPB1 T-cell epitope model for mismatched UR-HCT

Satoko Morishima

Blood (2024) 144 (16): 1659–1661.

https://doi.org/10.1182/blood.2024026286

Published: 2024

Journal Articles

Valemetostat for Relapsed or Refractory Peripheral T-Cell Lymphomas: Primary Results from a Phase 1 Trial

Blood (2023) 142 (Supplement 1): 303.

https://doi.org/10.1182/blood-2023-172512

Published: 2023

Journal Articles

The HLA-B Leader MM Genotype Has a Negative Impact on Outcomes in HLA-B One Antigen Mismatched and HLA-B Matched Cord Blood Transplantation without Anti-Thymocyte Globulin: Analysis of the Japanese Society for Transplantation and Cellular Therapy

Blood (2023) 142 (Supplement 1): 1048.

https://doi.org/10.1182/blood-2023-178905

Published: 2023

Journal Articles

Antibody-mediated pathogenesis of chronic GVHD through DBY/HLA class II complexes and induction of a GVL effect

Blood (2023) 142 (11): 1008–1021.

https://doi.org/10.1182/blood.2023019799

Published: 2023

Includes: Supplemental data

Journal Articles

An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia/lymphoma

Blood (2023) 141 (10): 1159–1168.

https://doi.org/10.1182/blood.2022016862

Published: 2023

Includes: Supplemental data

Journal Articles

Durable Clinical Impacts and Mechanisms of Action and Resistance in EZH1/2-Targeting Epigenetic Therapy

Blood (2022) 140 (Supplement 1): 756–757.

https://doi.org/10.1182/blood-2022-159275

Published: 2022

Journal Articles

Indirectly Recognizable Epitopes Derived from Recipient Mismatched HLA-B Are Associated with Adverse Prognosis in Single-Unit Cord Blood Transplantation

Takeshi Sugio, Koji Kato, Naoyuki Uchida, Kohta Miyawaki, Matthias Niemann, Eric Spierings, Makoto Onizuka, Yasufumi Uehara, Masatsugu Tanaka, Noriko Doki, Tetsuya Eto, Hikaru Kobayashi, Yumiko Maruyama, Tatsuo Ichinohe, Junya Kanda, Yoshiko Atsuta, Satoko Morishima

Blood (2022) 140 (Supplement 1): 893–894.

https://doi.org/10.1182/blood-2022-164913

Published: 2022

Journal Articles

Impact of Human Leukocyte Antigen Epitope Matching on Outcomes after Unrelated Bone Marrow Transplantation

Makoto Iwasaki, Junya Kanda, Hidenori Tanaka, Takero Shindo, Noriko Doki, Takahiro Fukuda, Yukiyasu Ozawa, Tetsuya Eto, Naoyuki Uchida, Yuta Katayama, Keisuke Kataoka, Makoto Onizuka, Yoshinobu Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Satoko Morishima

Blood (2021) 138 (Supplement 1): 3914.

https://doi.org/10.1182/blood-2021-145686

Published: 2021

Journal Articles

Pivotal Phase 2 Study of the EZH1 and EZH2 Inhibitor Valemetostat Tosylate (DS-3201b) in Patients with Relapsed or Refractory Adult T-Cell Leukemia/Lymphoma

Blood (2021) 138 (Supplement 1): 303.

https://doi.org/10.1182/blood-2021-146657

Published: 2021

Journal Articles

HLA-B Leader Dimorphism Impacts on Outcomes of HLA-Matched Related/Unrelated Transplantation: Analysis of the Japanese Society for Transplantation and Cellular Therapy

Minoru Kanaya, Yasuo Morishima, Nobuyoshi Arima, Masahiro Hirayama, Souichi Shiratori, Noriko Doki, Yukiyasu Ozawa, Takahiro Fukuda, Masatsugu Tanaka, Masashi Sawa, Satoru Takada, Shuichi Ota, Toshiro Kawakita, Junya Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Satoko Morishima

Blood (2021) 138 (Supplement 1): 2919.

https://doi.org/10.1182/blood-2021-144669

Published: 2021

Journal Articles

Proteomic Profiling of HTLV-1 Carriers and ATL Patients Reveal TNFR2 As a Novel Diagnostic and Chemosensitivity Biomarker for ATL

Carmina Louise Hugo Guerrero, MS, Yoshiko Yamashita, PhD, Megumi Kuba-Miyara, PhD, Naoki Imaizumi, PhD, Shugo Sakihama, PhD, Masaki Hayashi, MD, Takashi Miyagi, MD PhD, Satoko Morishima, MD PhD, Kennosuke Karube, MD PhD, Yuetsu Tanaka, PhD, Hiroaki Masuzaki, MD PhD, Takuya Fukushima, MD PhD

Blood (2019) 134 (Supplement_1): 660.

https://doi.org/10.1182/blood-2019-129817

Published: 2019

Journal Articles

Somatic Mutations and Loss of Heterozygosity of HLA Genes Are Frequently Occurred and Tightly Associated with Poor Prognosis in Adult T Cell Leukemia-Lymphoma

Keita Tamaki, MD, Satoko Morishima, MD PhD, Shingo Suzuki, PhD, Atsuko Shigenari, Ikumi Nomura, Yutaro Yokota, Kazuho Morichika, MD, Yukiko Nishi, MD PhD, Sawako Nakachi, MD PhD, Shiki Okamoto, PhD, Kennosuke Karube, MD PhD, Takuya Fukushima, MD PhD, Takashi Shiina, PhD, Hiroaki Masuzaki, MD PhD

Blood (2019) 134 (Supplement_1): 2785.

https://doi.org/10.1182/blood-2019-128070

Published: 2019

Journal Articles

First-in-Human Study of the EZH1/2 Dual Inhibitor Valemetostat in Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) - Updated Results Focusing on Adult T-Cell Leukemia-Lymphoma (ATL)

Satoko Morishima, MD PhD, Kenji Ishitsuka, MD PhD, Koji Izutsu, MD PhD, Shigeru Kusumoto, MD PhD, Junya Makiyama, MD PhD, Atae Utsunomiya, MD, Kisato Nosaka, MD PhD, Takashi Ishida, MD PhD, Yoshitaka Imaizumi, MD PhD, Nobuhiko Yamauchi, MD, Kazushi Araki, DVM, PhD, Nobuaki Adachi, PhD, Tomonari Yamashita, Ryo Atsumi, PhD, Kunihiro Tsukasaki, MD PhD, Kensei Tobinai, MD PhD

Blood (2019) 134 (Supplement_1): 4025.

https://doi.org/10.1182/blood-2019-125507

Published: 2019

Journal Articles

Impact of Homozygous Conserved Extended HLA Haplotypes on Cord Blood Transplantation: Implications for Induced Pluripotent Stem Cell Banking and Transplantation

Yasuo Morishima, MD PhD, Satoko Morishima, MD PhD, Makoto Murata, MD PhD, Nobuyoshi Arima, MD PhD, Naoyuki Uchida, MD PhD, Yuji Ohno, MD PhD, Satoshi Takahashi, MD PhD, Yoshiko Matsuhashi, MD PhD, Makoto Onizuka, MD PhD, Tetsuya Eto, MD PhD, Yoshiko Atsuta, MD PhD, Takahiro Fukuda, MD PhD, Tatsuo Ichinohe, MD PhD, Shunichi Kato, MD PhD, Junya Kanda, MD

Blood (2018) 132 (Supplement 1): 2097.

https://doi.org/10.1182/blood-2018-99-110193

Published: 2018

Journal Articles

The Presence of Defective Epstein-Barr Virus (EBV) Infection in Patients with EBV-Associated Hematological Malignancy

Yusuke Okuno, MDPhD, Takayuki Murata, MD, PhD, Yoshitaka Sato, MD, PhD, Hideki Muramatsu, MD PhD, Yoshinori Ito, MD PhD, Takahiro Watanabe, D.MD, PhD, Tatsuya Okuno, MD, Norihiro Murakami, MD, Kenichi Yoshida, MD PhD, Akihisa Sawada, MD PhD, Masami Inoue, MD, Keisei Kawa, MD, PhD, Masao Seto, MD PhD, Koichi Ohshima, MDPhD, Yuichi Shiraishi, PhD, Kenichi Chiba, PhD, Hiroko Tanaka, BA, Satoru Miyano, PhD, Yohei Narita, PhD, Masahiro Yoshida, MD PhD, Fumi Goshima, PhD, Junichi Kawada, MD PhD, Tetsuya Nishida, MD PhD, Hitoshi Kiyoi, MD PhD, Seiichi Kato, MD, PhD, Shigeo Nakamura, MD PhD, Satoko Morishima, MD PhD, Shigeyoshi Fujiwara, MD, PhD, Norio Shimizu, PhD, Yasushi Isobe, MD, PhD, Masaaki Noguchi, MD, PhD, Atsushi Kikuta, MD, Keiji Iwatsuki, MD, PhD, Yoshiyuki Takahashi, MD, PhD, Seiji Kojima, MD PhD, Seishi Ogawa, MD PhD, Hiroshi Kimura, MD, Ph. D.

Blood (2018) 132 (Supplement 1): 1562.

https://doi.org/10.1182/blood-2018-99-113801

Published: 2018

Journal Articles

Evolutionary basis of HLA-DPB1 alleles affects acute GVHD in unrelated donor stem cell transplantation

Satoko Morishima, Takashi Shiina, Shingo Suzuki, Seishi Ogawa, Aiko Sato-Otsubo, Koichi Kashiwase, Fumihiro Azuma, Toshio Yabe, Masahiro Satake, Shunichi Kato, Yoshihisa Kodera, Takehiko Sasazuki, Yasuo Morishima

Blood (2018) 131 (7): 808–817.

https://doi.org/10.1182/blood-2017-08-801449

Published: 2018

Includes: Supplemental data

Journal Articles

Randomized Phase II Study of R-CHOP-14 Versus R-CHOP-14 Followed By Chaser As Induction Therapy for High-Dose Chemotherapy (HDT), LEED, and Autologous Stem-Cell Transplantation (ASCT) in Poor-Risk Diffuse Large B-Cell Lymphoma (DLBCL): Japan Clinical Oncology Group (JCOG) Study (JCOG0908)

Blood (2017) 130 (Supplement 1): 4127.

https://doi.org/10.1182/blood.V130.Suppl_1.4127.4127

Published: 2017

Journal Articles

Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome in Lymphoma Patients Receiving Hematopoietic Cell Transplantation

Satoshi Yamasaki, MD PhD, Ritsuro Suzuki, MD, Kaoru Hatano, Kentaro Fukushima, MD PhD, Hiroatsu Iida, MD PhD, Satoko Morishima, MD, Youko Suehiro, MD, Takahiro Fukuda, MD, Naoyuki Uchida, MD PhD, Takashi Uchiyama, MD, Yoshiko Atsuta, MD PhD, Junji Suzumiya, MD PhD

Blood (2016) 128 (22): 827.

https://doi.org/10.1182/blood.V128.22.827.827

Published: 2016

Journal Articles

Genome-wide surveillance of mismatched alleles for graft-versus-host disease in stem cell transplantation

Aiko Sato-Otsubo, Yasuhito Nannya, Koichi Kashiwase, Makoto Onizuka, Fumihiro Azuma, Yoshiki Akatsuka, Yasuko Ogino, Masahiro Satake, Masashi Sanada, Shigeru Chiba, Hiroh Saji, Hidetoshi Inoko, Giulia C. Kennedy, Ken Yamamoto, Satoko Morishima, Yasuo Morishima, Yoshihisa Kodera, Takehiko Sasazuki, Seishi Ogawa

Blood (2015) 126 (25): 2752–2763.

https://doi.org/10.1182/blood-2015-03-630707

Published: 2015

Includes: Supplemental data

Journal Articles

Biological significance of HLA locus matching in unrelated donor bone marrow transplantation

Blood (2015) 125 (7): 1189–1197.

https://doi.org/10.1182/blood-2014-10-604785

Published: 2015

Includes: Supplemental data

NARROW

New HLA-DPB1 T-cell epitope model for mismatched UR-HCT

Valemetostat for Relapsed or Refractory Peripheral T-Cell Lymphomas: Primary Results from a Phase 1 Trial

The HLA-B Leader MM Genotype Has a Negative Impact on Outcomes in HLA-B One Antigen Mismatched and HLA-B Matched Cord Blood Transplantation without Anti-Thymocyte Globulin: Analysis of the Japanese Society for Transplantation and Cellular Therapy

Antibody-mediated pathogenesis of chronic GVHD through DBY/HLA class II complexes and induction of a GVL effect

An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia/lymphoma

Durable Clinical Impacts and Mechanisms of Action and Resistance in EZH1/2-Targeting Epigenetic Therapy

Indirectly Recognizable Epitopes Derived from Recipient Mismatched HLA-B Are Associated with Adverse Prognosis in Single-Unit Cord Blood Transplantation

Impact of Human Leukocyte Antigen Epitope Matching on Outcomes after Unrelated Bone Marrow Transplantation

Pivotal Phase 2 Study of the EZH1 and EZH2 Inhibitor Valemetostat Tosylate (DS-3201b) in Patients with Relapsed or Refractory Adult T-Cell Leukemia/Lymphoma

HLA-B Leader Dimorphism Impacts on Outcomes of HLA-Matched Related/Unrelated Transplantation: Analysis of the Japanese Society for Transplantation and Cellular Therapy

Proteomic Profiling of HTLV-1 Carriers and ATL Patients Reveal TNFR2 As a Novel Diagnostic and Chemosensitivity Biomarker for ATL

Somatic Mutations and Loss of Heterozygosity of HLA Genes Are Frequently Occurred and Tightly Associated with Poor Prognosis in Adult T Cell Leukemia-Lymphoma

First-in-Human Study of the EZH1/2 Dual Inhibitor Valemetostat in Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) - Updated Results Focusing on Adult T-Cell Leukemia-Lymphoma (ATL)

Impact of Homozygous Conserved Extended HLA Haplotypes on Cord Blood Transplantation: Implications for Induced Pluripotent Stem Cell Banking and Transplantation

The Presence of Defective Epstein-Barr Virus (EBV) Infection in Patients with EBV-Associated Hematological Malignancy

Evolutionary basis of HLA-DPB1 alleles affects acute GVHD in unrelated donor stem cell transplantation

Randomized Phase II Study of R-CHOP-14 Versus R-CHOP-14 Followed By Chaser As Induction Therapy for High-Dose Chemotherapy (HDT), LEED, and Autologous Stem-Cell Transplantation (ASCT) in Poor-Risk Diffuse Large B-Cell Lymphoma (DLBCL): Japan Clinical Oncology Group (JCOG) Study (JCOG0908)

Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome in Lymphoma Patients Receiving Hematopoietic Cell Transplantation

Genome-wide surveillance of mismatched alleles for graft-versus-host disease in stem cell transplantation

Biological significance of HLA locus matching in unrelated donor bone marrow transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only